相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aldosterone Increases Early Atherosclerosis and Promotes Plaque Inflammation Through a Placental Growth Factor-Dependent Mechanism
Adam P. McGraw et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Effects of Aldosterone on Human Atherosclerosis: Plasma Aldosterone and Progression of Carotid Plaque
Omar de Rita et al.
CANADIAN JOURNAL OF CARDIOLOGY (2012)
Smooth muscle cell phenotypic switching in atherosclerosis
Delphine Gomez et al.
CARDIOVASCULAR RESEARCH (2012)
Contribution of Endogenous Glucocorticoids and Their Intravascular Metabolism by 11β-HSDs to Postangioplasty Neointimal Proliferation in Mice
Javaid Iqbal et al.
ENDOCRINOLOGY (2012)
Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure
Fabrice Ivanes et al.
EUROPEAN HEART JOURNAL (2012)
Endogenous aldosterone is involved in vascular calcification in rat
Sheng-Ying Wu et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2012)
Altered Functioning of Both Renal Dopamine D1 and Angiotensin II Type 1 Receptors Causes Hypertension in Old Rats
Gaurav Chugh et al.
HYPERTENSION (2012)
Eplerenone Reduced Lesion Size in Early but Not Advanced Atherosclerosis in Apolipoprotein E-Deficient Mice
Ayelet Raz-Pasteur et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2012)
SM-368229, a Novel Promising Mineralocorticoid Receptor Antagonist, Shows Antihypertensive Efficacy With Minimal Effect on Serum Potassium Level in Rats
Tetsuro Nariai et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2012)
Vascular Disturbances in Primary Aldosteronism: Clinical Evidence
J. Widimsky et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2012)
Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury
James M. Luther et al.
KIDNEY INTERNATIONAL (2012)
Mineralocorticoid receptors in vascular function and disease
Amy McCurley et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors
Amy McCurley et al.
NATURE MEDICINE (2012)
Spironolactone Lowers Portal Hypertension by Inhibiting Liver Fibrosis, ROCK-2 Activity and Activating NO/PKG Pathway in the Bile-Duct-Ligated Rat
Wei Luo et al.
PLOS ONE (2012)
Antihypertensive and Cardiorenal Protective Effects of SM-368229, a Novel Mineralocorticoid Receptor Antagonist, in Aldosterone/Salt-Treated Rats
Tetsuro Nariai et al.
PHARMACOLOGY (2012)
Nongenomic actions of aldosterone and progesterone revisited
Alexandra Wendler et al.
STEROIDS (2012)
Measuring and targeting aldosterone and renin in atherosclerosis-A review of clinical data
Marieke A. Hillaert et al.
AMERICAN HEART JOURNAL (2011)
Reduced Dietary Salt for the Prevention of Cardiovascular Disease: A Meta-Analysis of Randomized Controlled Trials (Cochrane Review)
Rod S. Taylor et al.
AMERICAN JOURNAL OF HYPERTENSION (2011)
Aldosterone Regulates Vascular Gene Transcription via Oxidative Stress-Dependent and -Independent Pathways
Brenna G. Newfell et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PIGF
Charlotte Rolny et al.
CANCER CELL (2011)
Chronic Antagonism of the Mineralocorticoid Receptor Ameliorates Hypertension and End Organ Damage in a Rodent Model of Salt-Sensitive Hypertension
Xiaoyan Zhou et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2011)
11 beta-Hydroxysteroid Dehydrogenase Type 2 Deficiency Accelerates Atherogenesis and Causes Proinflammatory Changes in the Endothelium in Apoe(-/-) Mice
Graeme A. Deuchar et al.
ENDOCRINOLOGY (2011)
Fatal and Nonfatal Outcomes, Incidence of Hypertension, and Blood Pressure Changes in Relation to Urinary Sodium Excretion
Katarzyna Stolarz-Skrzypek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The immune system in atherosclerosis
Goran K. Hansson et al.
NATURE IMMUNOLOGY (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Long-term use of low-dose spironolactone in spontaneously hypertensive rats: Effects on left ventricular hypertrophy and stiffness
Marcelo P. Baldo et al.
PHARMACOLOGICAL REPORTS (2011)
Initiation of Angiogenesis in Atherosclerosis: Smooth Muscle Cells as Mediators of the Angiogenic Response to Atheroma Formation
Benoit Ho-Tin-Noe et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2011)
Inducible renal principal cell-specific mineralocorticoid receptor gene inactivation in mice
Caroline Ronzaud et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Hypertension in aging patients
Alexander G. Logan
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2011)
Progenitor cell-derived smooth muscle cells in vascular disease
Augusto Orlandi et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions
Carmen Roncal et al.
CARDIOVASCULAR RESEARCH (2010)
Expanding view of aldosterone action, with an emphasis on rapid action
Gavin P. Vinson et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2010)
A Randomized, Double-Blind, Placebo-Controlled Trial of Spironolactone on Carotid Intima-Media Thickness in Nondiabetic Hemodialysis Patients
Antonio Vukusich et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Elevated Mineralocorticoid Receptor Activity in Aged Rat Vascular Smooth Muscle Cells Promotes a Proinflammatory Phenotype via Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase and Epidermal Growth Factor Receptor-Dependent Pathways
Alexander W. Krug et al.
HYPERTENSION (2010)
Placental growth factor mediates aldosterone-dependent vascular injury in mice
Iris Z. Jaffe et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Complex Regulation and Function of the Inflammatory Smooth Muscle Cell Phenotype in Atherosclerosis
Anthony Wayne Orr et al.
JOURNAL OF VASCULAR RESEARCH (2010)
Mechanisms of Vascular Aging: New Perspectives
Zoltan Ungvari et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2010)
Angiotensin receptors as determinants of life span
Paola Cassis et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
Human IL-8 Regulates Smooth Muscle Cell VCAM-1 Expression in Response to Endothelial Cells Exposed to Atheroprone Flow
Nicole E. Hastings et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Blood pressure control in the elderly: Can you have too much of a good thing?
David J. Hyman et al.
CURRENT HYPERTENSION REPORTS (2009)
Role of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Hypertension in Patients Aged >= 65 Years
Alan H. Gradman
DRUGS & AGING (2009)
Aldosterone Increases Oxidant Stress to Impair Guanylyl Cyclase Activity by Cysteinyl Thiol Oxidation in Vascular Smooth Muscle Cells
Bradley A. Maron et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Rapid Aldosterone Signaling and Vascular Reactivity: Relax or Don't Do It
Jane A. Leopold
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Disruption of the Ang II type 1 receptor promotes longevity in mice
Ariela Benigni et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology
John W. Funder et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways
A. C. Montezano et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism
Giampaolo Bernini et al.
JOURNAL OF HYPERTENSION (2008)
Prehypertensive renin-angiotensin-aldosterone system blockade in spontaneously hypertensive rats ameliorates the loss of long-term vascular function
Marcus Baumann et al.
HYPERTENSION RESEARCH (2007)
Proinflammatory profile within the grossly normal aged human aortic wall
Mingyi Wang et al.
HYPERTENSION (2007)
Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension
Robert Holaj et al.
JOURNAL OF HYPERTENSION (2007)
Impairment of sodium balance in mice deficient in renal principal cell mineralocorticoid receptor
Caroline Ronzaud et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter
Claudia Grossmann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Mineralocorticoid receptor activation promotes vascular cell calcification
Iris Z. Jaffe et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Vascular calcification - Pathobiological mechanisms and clinical implications
Rebecca C. Johnson et al.
CIRCULATION RESEARCH (2006)
Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker
Miki Nagase et al.
HYPERTENSION (2006)
Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats
K Nagata et al.
HYPERTENSION (2006)
Eplerenone suppresses neointimal formation after coronary stent implantation in swine
K Wakabayashi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells
K Miyata et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells
LJ Min et al.
CIRCULATION RESEARCH (2005)
Eplerenone reduces oxidative stress and enhances eNOS in SHR:: Vascular functional and structural consequences
D Sanz-Rosa et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats:: role of the NFκB/IκB system
D Sanz-Rosa et al.
JOURNAL OF HYPERTENSION (2005)
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
P Milliez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells
IZ Jaffe et al.
CIRCULATION RESEARCH (2005)
Eplerenone blocks nongenomic effects of aldosterone on the Na+/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels
L Michea et al.
ENDOCRINOLOGY (2005)
The biology of cyclic GMP-dependent protein kinases
F Hofmann
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulation of epithelial ion transport by aldosterone through changes in gene expression
A Bhargava et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Distinguishing the antihypertensive and electrolyte effects of eplerenone
DG Levy et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature
GH Dai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development - A possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone
S Keidar et al.
CIRCULATION (2004)
Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling
Q Pu et al.
HYPERTENSION (2003)
Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates
MY Wang et al.
HYPERTENSION (2003)
Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice
S Keidar et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
Spironolactone improves angiotensin-induced vascular changes and oxidative stress
A Virdis et al.
HYPERTENSION (2002)
Mineralocorticoid receptor antagonism in experimental atherosclerosis
S Rajagopalan et al.
CIRCULATION (2002)
Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries
MR Ward et al.
CIRCULATION (2001)
Adrenal and sex steroid receptor evolution: environmental implications
ME Baker
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2001)
Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats
P Lacolley et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
The EPHESUS trial: Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction
B Pitt et al.
CARDIOVASCULAR DRUGS AND THERAPY (2001)
Aldosterone mediates angiotensin II-stimulated rat vascular smooth muscle cell proliferation
F Xiao et al.
JOURNAL OF ENDOCRINOLOGY (2000)
Mineralocorticoid receptor knockout mice:: Lessons on Na+ metabolism
S Berger et al.
KIDNEY INTERNATIONAL (2000)
Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats
W Linz et al.
HYPERTENSION (2000)
分享论文
